Rachel Nuwer is a freelance science journalist who regularly contributes to The New York Times, Nature, Scientific American and more. Her latest book is “I Feel Love: MDMA and the Quest for Connection in a Fractured World.” She is also adjunct professor of science journalism at New York University.
Rachel Nuwer
Contributing writer
From this contributor
Lisa Croen: Autism’s first dedicated epidemiologist
Inspired by watching her autistic nephew grow up, Croen has also been an advocate for bolstering research and services for autistic adults.
Lisa Croen: Autism’s first dedicated epidemiologist
By
Rachel Nuwer
28 March 2022 | 9 min read
Finding strengths in autism
Autism comprises a set of difficulties, but growing evidence suggests that certain abilities also define the condition.
Meet the autistic scientists redefining autism research
Growing ranks of researchers on the spectrum are overcoming barriers — from neurotypical bias to sensory sensitivities — to shape autism science.
Meet the autistic scientists redefining autism research
By
Rachel Nuwer
10 June 2020 | 18 min read
Growing old with autism
For many autistic adults, the golden years are tarnished by poor health, poverty and, in some cases, homelessness. Their plight reveals huge gaps in care.
Mouse study links gene to some autism symptoms
Mice missing a gene called PTCHD1 in a deep-seated brain structure have autism-like symptoms that ease with treatment.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read